Imagine a painful, itchy rash that thrives in the warm, moist folds of your skin—your armpits, groin, or under your breasts. That's inverse psoriasis, and it can be incredibly difficult to treat. Doctors recently tried a newer psoriasis medication, guselkumab, on a 48-year-old man with this condition. After three injections over 12 weeks, his skin lesions and the relentless itching showed marked improvement. This is a promising result for a single patient, offering a glimmer of hope where treatment options are often limited. However, it's crucial to remember this is just one case. We have no way of knowing if this drug would help another person with the same condition, and we don't have any information on side effects or how long the improvement might last. The finding is a starting point for asking new questions, not a proven solution.
Can a psoriasis drug help with a rare, hard-to-treat skin condition?
Photo by Dmytro Vynohradov / Unsplash
What this means for you:
One patient improved, but it's too soon to know if this treatment works for others. More on Inverse Psoriasis
Guselkumab Phase III trials validate 3VAS and 4VAS measures for psoriatic arthritis disease activity assessment Study checks how well pain scores track joint damage in psoriatic arthritis patients
· Apr 16, 2026
Guselkumab showed improved clinical remission in refractory ulcerative colitis versus placebo Guselkumab shows promise for ulcerative colitis in this early phase 3 trial.
· Apr 15, 2026
Guselkumab Shows Promise in Crohn's Disease: Phase 3 Study Results Can a new treatment help people with Crohn's disease feel better and stay better?
CT.gov · Mar 28, 2026